I kēia mau lā iho nei, ua ʻāpono ka National Medical Products Administration (NMPA) i kahi hōʻailona hou no ka antibody-drug conjugate (ADC) Disitamab vedotin no ka mālama ʻana i nā poʻe maʻi maʻi umauma makua me ka unresectable a metastatic HER2-low expression (IHC 1+ a i ʻole IHC 2+/ISH-) a me nā metastases o ke ake, ka poʻe i loaʻa mua ma ka liʻiliʻi o hoʻokahi systemic therapy i ka metastatic setting, a i ʻole ua relapsed i loko a i ʻole i loko o 12 mau mahina o ka hoʻopau ʻana i ka adjuvant chemotherapy.
ʻO kēia ka hōʻailona ʻehā i ʻāpono ʻia no Disitamab vedotin ma Kina, ma hope o kāna mau ʻāpono mua no ka maʻi ʻaʻai gastric, urothelial carcinoma, a me ka maʻi ʻaʻai umauma holomua HER2-positive me nā metastases ate.
ʻO nā hōʻike lapaʻau e kākoʻo ana i kēia hōʻailona hou e pili ana i kahi hoʻokolohua lapaʻau randomized, open-label, parallel-controlled, multicenter Phase III (RC48-C012) i mālama ʻia ma Kina. Ua hōʻike ke aʻo ʻana i ka pono a me ka palekana o Disitamab vedotin i ka mālama ʻana i nā poʻe maʻi maʻi umauma makua me ka unresectable a metastatic HER2-low expression (IHC 1+ a i ʻole IHC 2+/ISH-) a me nā metastases o ke ake, ka poʻe i loaʻa mua ma ka liʻiliʻi o hoʻokahi systemic therapy i ka hoʻonohonoho metastatic, a i ʻole ua relapsed i ka wā a i loko o 12 mau mahina o ka hoʻopau ʻana i ka chemotherapy adjuvant.
Inā ʻoe a i ʻole kou ʻohana e kū nei i kēlā ʻano maʻi a makemake ʻoe e aʻo e pili ana i nā koho lapaʻau hou loa, ua hoʻolaʻa ʻia ka International Department of Beijing South Region Oncology Hospital i ka hāʻawi ʻana i nā maʻi honua me nā lawelawe lapaʻau holomua a me ka mālama multidisciplinary e kūlike me nā kūlana honua. Hiki i kā mākou hui ke kōkua iā ʻoe i ke komo ʻana i nā lāʻau lapaʻau kiʻekiʻe a me ka launa pū ʻana me nā loea alakaʻi, e hōʻoiaʻiʻo ana i kahi ʻike lapaʻau ʻoihana, kūpono, a pilikino hoʻi ma Kina.
**E leka uila mai iā mākou i kēia lā e hoʻomaka i kāu huakaʻi i ka hoʻōla a me ke kūkākūkā ʻana:**
- **Laina Kōkua:** 400-880-3716 (loaʻa 24/7)
- **WeChat:** 17801183037 (e hoʻohui iā mākou no ke kamaʻilio koke ʻana)
- **Leka uila:**
- 100085_010@163.com
- myimmnet@163.com
Ma hea ʻoe e noho ai, lawelawe ka International Department of Beijing South Region Oncology Hospital ma ke ʻano he alahaka paʻa no ʻoe e komo ai i nā kumuwaiwai lapaʻau kiʻekiʻe ma waena o nā palena. E hana pū kākou e hoʻolilo i nā holomua lapaʻau hou loa i manaʻolana hou no kou ola.
Ka manawa hoʻouna: Malaki-24-2026